Xponance’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.33M | Sell |
15,865
-402
| -2% | -$211K | 0.07% | 223 |
|
|
2025
Q1 | $10.3M | Sell |
16,267
-5
| -0% | -$3.17K | 0.1% | 164 |
|
|
2024
Q4 | $11.6M | Buy |
16,272
+482
| +3% | +$343K | 0.11% | 152 |
|
|
2024
Q3 | $16.6M | Buy |
15,790
+289
| +2% | +$304K | 0.16% | 102 |
|
|
2024
Q2 | $16.3M | Sell |
15,501
-28
| -0.2% | -$29.4K | 0.17% | 96 |
|
|
2024
Q1 | $14.9M | Buy |
15,529
+1,153
| +8% | +$1.11M | 0.16% | 116 |
|
|
2023
Q4 | $12.6M | Buy |
14,376
+852
| +6% | +$748K | 0.15% | 120 |
|
|
2023
Q3 | $11.1M | Sell |
13,524
-1,062
| -7% | -$874K | 0.15% | 117 |
|
|
2023
Q2 | $10.5M | Sell |
14,586
-795
| -5% | -$571K | 0.14% | 120 |
|
|
2023
Q1 | $12.6M | Buy |
15,381
+432
| +3% | +$355K | 0.18% | 104 |
|
|
2022
Q4 | $10.8M | Buy |
14,949
+2,018
| +16% | +$1.46M | 0.17% | 115 |
|
|
2022
Q3 | $8.91M | Buy |
12,931
+502
| +4% | +$346K | 0.17% | 111 |
|
|
2022
Q2 | $7.35M | Sell |
12,429
-973
| -7% | -$575K | 0.15% | 123 |
|
|
2022
Q1 | $9.36M | Buy |
13,402
+202
| +2% | +$141K | 0.16% | 112 |
|
|
2021
Q4 | $8.34M | Buy |
13,200
+6,838
| +107% | +$4.32M | 0.13% | 138 |
|
|
2021
Q3 | $3.85M | Sell |
6,362
-462
| -7% | -$280K | 0.07% | 217 |
|
|
2021
Q2 | $3.81M | Sell |
6,824
-7,731
| -53% | -$4.32M | 0.07% | 228 |
|
|
2021
Q1 | $6.89M | Sell |
14,555
-40
| -0.3% | -$18.9K | 0.15% | 134 |
|
|
2020
Q4 | $7.05M | Sell |
14,595
-7,067
| -33% | -$3.41M | 0.15% | 119 |
|
|
2020
Q3 | $12.1M | Sell |
21,662
-1,491
| -6% | -$835K | 0.3% | 64 |
|
|
2020
Q2 | $14.4M | Buy |
+23,153
| New | +$14.4M | 0.37% | 55 |
|